货号:A177703
同义名:
紫丁香苷
/ Eleutheroside B; NSC 287441
Syringin是从紫丁香(Syringa vulgaris)果实中提取的天然产物,具有抗肿瘤、抗增殖、抗炎和镇痛作用。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBI-0206965 |
+++
ULK2, IC50: 711 nM ULK1, IC50: 108 nM |
99% | |||||||||||||||||
Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
PFK-015 |
++
PFKFB3, IC50: 207 nM |
99%+ | |||||||||||||||||
MRT68921 HCl |
++++
ULK2, IC50: 1.1 nM ULK1, IC50: 2.9 nM |
99%+ | |||||||||||||||||
ROC-325 | ✔ | 99%+ | |||||||||||||||||
Autophinib |
+++
Autophagy, IC50: 40 nM |
99% | |||||||||||||||||
Lys05 | ✔ | 99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Syringin is a natural product isolated and purified from the fruits of Syringa vulgaris with antitumour,antiproliferative, anti-inflammatory and antinociceptive effects. |
Concentration | Treated Time | Description | References | |
N2a cells | 1 mM | 6 h | To evaluate the protective effects of Syringin on N2a and APPswe cells under oxidative stress conditions. Results showed that Syringin pretreatment significantly reduced H2O2-induced ROS production and apoptosis, and improved cell cycle delay. | Redox Biol. 2020 Sep;36:101672. |
Rabbit atrial myocytes | 200 μM | Syringin significantly suppressed ATX II-induced Na+-dependent [Ca2+]i overload. | Acta Pharmacol Sin. 2021 Feb;42(2):209-217. | |
Rabbit atrial myocytes | 300 μM | Syringin significantly reduced ATX II-prolonged APD90 and eliminated ATX II-induced EADs, DADs, and TAs. | Acta Pharmacol Sin. 2021 Feb;42(2):209-217. | |
Rabbit atrial myocytes | 167 μM | Syringin concentration-dependently inhibited INaL, INaT, and ATX II-increased INaL with IC50 values of 167, 1582, and 181 μM, respectively. | Acta Pharmacol Sin. 2021 Feb;42(2):209-217. | |
MDA-MB-231 cells | 0, 20, 40, 80, 160, and 320 µg/mL | 24 h and 48 h | Syringin significantly inhibited the proliferation of MDA-MB-231 cells with an IC50 of 228.8 µg/mL (48 h). | J Transl Med. 2022 Jul 6;20(1):310. |
MCF-7 cells | 0, 20, 40, 80, 160, and 320 µg/mL | 24 h and 48 h | Syringin significantly inhibited the proliferation of MCF-7 cells with an IC50 of 207.9 µg/mL (48 h). | J Transl Med. 2022 Jul 6;20(1):310. |
SH-SY5Y cells | 2-4 μM | 24 h | SRG pretreatment dose-dependently reduced 6-OHDA-induced cell death, with 4 μM SRG increasing cell survival rate by 1.6-fold | Cells. 2023 Sep 19;12(18):2310. |
NSC-34 mouse motor neuron cells | 0.25-8 μM | 24 h | Syringin improved PR-CM-induced motor neuron death and apoptosis | Cells. 2022 Oct 5;11(19):3128. |
Administration | Dosage | Frequency | Description | References | ||
APP/PS1 transgenic mice and wild-type C57BL/6 mice | Alzheimer's disease model | Oral gavage | 20 mg/kg and 60 mg/kg | Once daily for five months | To evaluate the effects of Syringin on cognitive deficits and AD-related pathology in APP/PS1 mice. Results showed that Syringin treatment significantly improved cognitive function, reduced Aβ deposition, and enhanced synaptic plasticity in APP/PS1 mice. | Redox Biol. 2020 Sep;36:101672. |
New Zealand white rabbits | Langendorff-perfused rabbit heart model | Perfusion | 200 μM | 100 minutes | EB substantially decreased ATX II-induced incidences of atrial fibrillation (AF), ventricular fibrillation (VF), and heart death. | Acta Pharmacol Sin. 2021 Feb;42(2):209-217. |
Caenorhabditis elegans | BZ555 (Pdat-1::GFP), NL5901 (Punc-54::α-Syn::YFP), DA2123 (lgg-1p::GFP::lgg-1), and VC199 (sir2.1 (ok434)) | Culture medium treatment | 1 mM | Pretreatment for 24 hours, then exposed to 6-OHDA for 1 hour | SRG pretreatment ameliorated 6-OHDA-induced degeneration of DA neurons, dopamine-mediated food-sensitive behavioral abnormalities, and shortened lifespan, and enhanced autophagic activity by upregulating the sir-2.1 pathway | Cells. 2023 Sep 19;12(18):2310. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.69mL 0.54mL 0.27mL |
13.43mL 2.69mL 1.34mL |
26.86mL 5.37mL 2.69mL |
CAS号 | 118-34-3 |
分子式 | C17H24O9 |
分子量 | 372.37 |
SMILES Code | COC(C=C(C=C1OC)/C=C/CO)=C1O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O |
MDL No. | MFCD00016778 |
别名 | 紫丁香苷 ;Eleutheroside B; NSC 287441; Lilacin; Syringoside |
运输 | 蓝冰 |
InChI Key | QJVXKWHHAMZTBY-GCPOEHJPSA-N |
Pubchem ID | 5316860 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 105 mg/mL(281.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|